Rimonabant是一个大脑中心大麻素受体(CB1)特异性口服拮抗剂。在hCB1转染HEK293细胞中IC50浓度为13.6 nM,EC50浓度为17.3 nM。
别名:SR141716
Rimonabant is the first selective and orally active antagonist of the central brain cannabinoid receptor (CB1) with IC50 with 13.6 nM and EC50 with 17.3 nM in hCB1 transfected HEK 293 membrane .Rimonabant has been used to afford weight reduction and improvements in cardiometabolic risk factors, however is withdrawn in 2009 due to the severe depressive disorder and anxiety.Besides CB1 inhibition ability, Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2 . Moreover, Rimonabant significantly reduces cell growth and induces cell death of human colorectal cancer cells (DLD-1, CaCo-2 and SW620). Rimonabant is able to alter cell cycle distribution in all the cell lines tested. In the mouse model of azoxymethane-induced colon carcinogenesis, Rimonabant significantly decreased aberrant crypt foci (ACF) formation, which precedes colorectal cancer . Meanwhile, Rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats .
分子量 | 463.79 |
分子式 | C22H21Cl3N4O |
CAS号 | 168273-06-1 |
溶解性(25°C) | DMSO 12 mg/mL |
储存条件 |
粉末型式 -20°C 3年;4°C 2年 溶于溶剂 -80°C 6个月;-20°C 1个月 |
运输方式 | 冰袋运输,根据产品的不同,可能会有相应调整。 |
*下述溶液配置方法仅为基于分子量计算出的理论值。不同产品在配置溶液前,需考虑其在不同溶剂中的溶解度限制。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.1561 mL | 10.7807 mL | 21.5615 mL |
5 mM | 0.4312 mL | 2.1561 mL | 4.3123 mL |
10 mM | 0.2156 mL | 1.0781 mL | 2.1561 mL |
小鼠 | 大鼠 | 兔 | 豚鼠 | 仓鼠 | 狗 | |
重量 (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
体表面积 (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km 系数 | 3 | 6 | 12 | 8 | 5 | 20 |
动物 A (mg/kg) = 动物 B (mg/kg) × | 动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
[1] Ashish Samat, et al. Rimonabant for the treatment of obesity
[2] M Soyka. Rimonabant and depression
[3] A S Wierzbicki. Rimonabant: endocannabinoid inhibition for the metabolic syndrome
[4] C Curioni, et al. Rimonabant for overweight or obesity
[5] Steven Thomas Boyd, et al. Rimonabant--a selective CB1 antagonist
其他相关的Cannabinoid产品 |
---|
Vicasinabin
Vicasinabin (RG7774) 是一种 cannabinoid receptor 2 (CB2) 的有效激动剂。 |
INV-347
INV-347 是一种 CB1R 逆向激动剂,可用于肥胖的相关研究。 |
RVD-Hpα TFA
RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allos 웿 |
Hemopressin(human, mouse) TFA
Hemopressin TFA 是一种源自血红蛋白 α1 链的九肽,最初是从大鼠脑匀浆中分离出来的。 |
Hemopressin(rat) TFA
Hemopressin(rat) TFA 是一种源自血红蛋白 α1 链的九肽,最初是从大鼠脑匀浆中分离出来的。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号